- Home
- HRI vs GH Comparison
HRI vs GH Comparison
Compare HRI & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRI
- GH
- Stock Information
- Founded
- HRI 1965
- GH 2011
- Country
- HRI United States
- GH United States
- Employees
- HRI N/A
- GH N/A
- Industry
- HRI Misc Corporate Leasing Services
- GH Medical Specialities
- Sector
- HRI Industrials
- GH Health Care
- Exchange
- HRI Nasdaq
- GH Nasdaq
- Market Cap
- HRI 4.2B
- GH 4.9B
- IPO Year
- HRI N/A
- GH 2018
- Fundamental
- Price
- HRI $128.15
- GH $58.80
- Analyst Decision
- HRI Buy
- GH Strong Buy
- Analyst Count
- HRI 5
- GH 17
- Target Price
- HRI $144.60
- GH $58.24
- AVG Volume (30 Days)
- HRI 411.5K
- GH 2.3M
- Earning Date
- HRI 10-21-2025
- GH 11-05-2025
- Dividend Yield
- HRI 2.17%
- GH N/A
- EPS Growth
- HRI N/A
- GH N/A
- EPS
- HRI 0.79
- GH N/A
- Revenue
- HRI $3,779,000,000.00
- GH $828,849,000.00
- Revenue This Year
- HRI $25.20
- GH $28.07
- Revenue Next Year
- HRI $14.26
- GH $21.61
- P/E Ratio
- HRI $162.82
- GH N/A
- Revenue Growth
- HRI 11.41
- GH 28.74
- 52 Week Low
- HRI $96.19
- GH $20.14
- 52 Week High
- HRI $246.88
- GH $68.00
- Technical
- Relative Strength Index (RSI)
- HRI 48.81
- GH 53.29
- Support Level
- HRI $124.83
- GH $53.40
- Resistance Level
- HRI $136.14
- GH $61.95
- Average True Range (ATR)
- HRI 6.23
- GH 2.54
- MACD
- HRI -0.50
- GH -0.95
- Stochastic Oscillator
- HRI 23.56
- GH 36.99
About HRI Herc Holdings Inc.
Herc Holdings is an equipment rental company that was spun out of Hertz Global in 2016. It is the third-largest player in North America, after United Rentals and Sunbelt Rentals, with an approximate 6% market share pro forma for its 2025 acquisition of H&E Equipment Services. It serves a similar mix of companies to its peers (industrial, commercial, and residential construction) from its 450 locations targeting the top 100 metropolitan markets in the US. Herc's rental fleet of approximately $7 billion is also similar in composition to its peer group in terms of equipment offered. The company is pursuing diversification by bundling and increasing specialty solutions for its customer base. Herc's portfolio skews toward local customers versus national accounts (60/40).
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.